Chartwell Investment Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Chartwell Investment Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-22,287	Closed	-$3.84M	–	430
2019 Q2	$3.84M	Buy	22,287 +8,171	+58%	+$1.41M	0.13%	235
2019 Q1	$2.38M	Buy	+14,116	New	+$2.1M	0.08%	309
2017 Q3	–	Sell	-16,701	Closed	-$1.67M	–	448
2017 Q2	$1.67M	Buy	16,701 +6	+0%	+$646	0.06%	313
2017 Q1	$2.02M	Sell	16,695 -7,265	-30%	-$891K	0.07%	291
2016 Q4	$2.68M	Buy	+23,960	New	+$2.88M	0.09%	285

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chartwell Investment Partners's GWPH Position: Q3 2019 in Review

Chartwell Investment Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 22,287 shares — an estimated $3.84M sold.

Chartwell Investment Partners first reported a position in GWPH in Q4 2016 and held it in 5 quarters. The position peaked at $3.84M in Q2 2019. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Chartwell Investment Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Chartwell Investment Partners sold 22,287 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $3.84M.
Chartwell Investment Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 5 quarters.
Chartwell Investment Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.84M in Q2 2019.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Chartwell Investment Partners's 13F filing for Q3 2019, filed 29 Oct 2019.